Veracyte, Inc.
VCYT· Nasdaq
VCYTVeracyte, Inc.
Filed Nov 7, 2017 · 10-Q · 38 days after period end · 0001384101-17-000068
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $17.52M | $18.60M | $12.34M | $9.84M |
| EPS Diluted | -$0.21 | -$0.20 | -$0.32 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Veracyte, Inc. · CIK 1384101 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 7, 2017 · 38 d after period end
